These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 27041524)

  • 21. Effect of a 6-month intervention with cooking oils containing a high concentration of monounsaturated fatty acids (olive and canola oils) compared with control oil in male Asian Indians with nonalcoholic fatty liver disease.
    Nigam P; Bhatt S; Misra A; Chadha DS; Vaidya M; Dasgupta J; Pasha QM
    Diabetes Technol Ther; 2014 Apr; 16(4):255-61. PubMed ID: 24625239
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of synbiotic supplementation on energy and macronutrients homeostasis and muscle wasting of critical care patients: study protocol and a review of previous studies.
    Seifi N; Safarian M; Nematy M; Rezvani R; Khadem-Rezaian M; Sedaghat A
    Trials; 2020 Feb; 21(1):221. PubMed ID: 32093741
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A double-blind randomized placebo-controlled trial of orlistat for the treatment of nonalcoholic fatty liver disease.
    Zelber-Sagi S; Kessler A; Brazowsky E; Webb M; Lurie Y; Santo M; Leshno M; Blendis L; Halpern Z; Oren R
    Clin Gastroenterol Hepatol; 2006 May; 4(5):639-44. PubMed ID: 16630771
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of lean patients with nonalcoholic fatty liver disease: potential role of high hemoglobin levels.
    Akyuz U; Yesil A; Yilmaz Y
    Scand J Gastroenterol; 2015 Mar; 50(3):341-6. PubMed ID: 25540973
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Flaxseed supplementation in non-alcoholic fatty liver disease: a pilot randomized, open labeled, controlled study.
    Yari Z; Rahimlou M; Eslamparast T; Ebrahimi-Daryani N; Poustchi H; Hekmatdoost A
    Int J Food Sci Nutr; 2016 Jun; 67(4):461-9. PubMed ID: 26983396
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of synbiotic food consumption on metabolic status of diabetic patients: a double-blind randomized cross-over controlled clinical trial.
    Asemi Z; Khorrami-Rad A; Alizadeh SA; Shakeri H; Esmaillzadeh A
    Clin Nutr; 2014 Apr; 33(2):198-203. PubMed ID: 23786900
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nonalcoholic fatty liver disease: portal hypertension due to outflow block in patients without cirrhosis.
    Hirooka M; Koizumi Y; Miyake T; Ochi H; Tokumoto Y; Tada F; Matsuura B; Abe M; Hiasa Y
    Radiology; 2015 Feb; 274(2):597-604. PubMed ID: 25302830
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypocaloric high-protein diet improves clinical and biochemical markers in patients with nonalcoholic fatty liver disease (NAFLD).
    Bezerra Duarte SM; Faintuch J; Stefano JT; Sobral de Oliveira MB; de Campos Mazo DF; Rabelo F; Vanni D; Nogueira MA; Carrilho FJ; Marques Souza de Oliveira CP
    Nutr Hosp; 2014 Jan; 29(1):94-101. PubMed ID: 24483967
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of a synbiotic supplementation in the prevention of common winter diseases in children: a randomized, double-blind, placebo-controlled pilot study.
    Cazzola M; Pham-Thi N; Kerihuel JC; Durand H; Bohbot S
    Ther Adv Respir Dis; 2010 Oct; 4(5):271-8. PubMed ID: 20729255
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Community-based lifestyle modification programme for non-alcoholic fatty liver disease: a randomized controlled trial.
    Wong VW; Chan RS; Wong GL; Cheung BH; Chu WC; Yeung DK; Chim AM; Lai JW; Li LS; Sea MM; Chan FK; Sung JJ; Woo J; Chan HL
    J Hepatol; 2013 Sep; 59(3):536-42. PubMed ID: 23623998
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mediterranean diet and non-alcoholic fatty liver disease: the need of extended and comprehensive interventions.
    Trovato FM; Catalano D; Martines GF; Pace P; Trovato GM
    Clin Nutr; 2015 Feb; 34(1):86-8. PubMed ID: 24529325
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of synbiotic on anthropometry, lipid profile and oxidative stress in obese children.
    Ipar N; Aydogdu SD; Yildirim GK; Inal M; Gies I; Vandenplas Y; Dinleyici EC
    Benef Microbes; 2015; 6(6):775-82. PubMed ID: 26259892
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combination of synbiotic and sitagliptin in nonalcoholic fatty liver disease: Is it better than sitagliptin alone?
    Cho YK
    Clin Mol Hepatol; 2018 Sep; 24(3):299-301. PubMed ID: 30196651
    [No Abstract]   [Full Text] [Related]  

  • 34. Omega-3 Fatty acids therapy in children with nonalcoholic Fatty liver disease: a randomized controlled trial.
    Janczyk W; Lebensztejn D; Wierzbicka-Rucińska A; Mazur A; Neuhoff-Murawska J; Matusik P; Socha P
    J Pediatr; 2015 Jun; 166(6):1358-63.e1-3. PubMed ID: 25771388
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A randomized, double blind, placebo-controlled trial of an oral synbiotic (AKSB) for prevention of travelers' diarrhea.
    Virk A; Mandrekar J; Berbari EF; Boyce TG; Fischer PR; Kasten MJ; Orenstein R; Rosenblatt JE; Sampathkumar P; Sia I; Springer D; Witzig TE
    J Travel Med; 2013; 20(2):88-94. PubMed ID: 23464715
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dihydromyricetin improves glucose and lipid metabolism and exerts anti-inflammatory effects in nonalcoholic fatty liver disease: A randomized controlled trial.
    Chen S; Zhao X; Wan J; Ran L; Qin Y; Wang X; Gao Y; Shu F; Zhang Y; Liu P; Zhang Q; Zhu J; Mi M
    Pharmacol Res; 2015 Sep; 99():74-81. PubMed ID: 26032587
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of Roux-en-Y gastric bypass and sleeve gastrectomy on nonalcoholic fatty liver disease: a comparative study.
    Froylich D; Corcelles R; Daigle C; Boules M; Brethauer S; Schauer P
    Surg Obes Relat Dis; 2016 Jan; 12(1):127-31. PubMed ID: 26077701
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolites of arachidonic acid and linoleic acid in early stages of non-alcoholic fatty liver disease--A pilot study.
    Maciejewska D; Ossowski P; Drozd A; Ryterska K; Jamioł-Milc D; Banaszczak M; Kaczorowska M; Sabinicz A; Raszeja-Wyszomirska J; Stachowska E
    Prostaglandins Other Lipid Mediat; 2015 Sep; 121(Pt B):184-9. PubMed ID: 26408952
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Perioperative synbiotics decrease postoperative complications in periampullary neoplasms: a randomized, double-blind clinical trial.
    Sommacal HM; Bersch VP; Vitola SP; Osvaldt AB
    Nutr Cancer; 2015; 67(3):457-62. PubMed ID: 25803626
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The add-on effects of Gynostemma pentaphyllum on nonalcoholic fatty liver disease.
    Chou SC; Chen KW; Hwang JS; Lu WT; Chu YY; Lin JD; Chang HJ; See LC
    Altern Ther Health Med; 2006; 12(3):34-9. PubMed ID: 16708768
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.